Dental Research Institute Schedules Virtual Grant Review Meeting
Published Date: 3/26/2025
Notice
Summary
The National Institute of Dental & Craniofacial Research is holding a virtual meeting on May 28, 2025, to discuss new research ideas and review grant applications. Anyone interested can watch the open session online for free, but some parts will be private to protect sensitive info. This meeting affects researchers and organizations seeking funding and guidance in dental and craniofacial health.
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
Open Session Videocast Available Free
You can watch the open session of the National Advisory Dental and Craniofacial Research Council meeting by videocast on May 28, 2025, from 10:00 a.m. to 1:30 p.m. Registration is not required and the videocast is available from the NIH Videocasting website.
Closed Sessions to Review Grant Applications
Portions of the meeting on May 28, 2025 (2:45 p.m. to 4:00 p.m.) will be closed to review and evaluate grant applications; discussions may include confidential trade secrets, patentable material, and personal information about applicants. This affects researchers and organizations that have submitted or plan to submit grant applications for dental and craniofacial research.
Submit Written Comments to the Committee
Any interested person may file written comments with the committee by sending a statement (including name, address, phone number and affiliation when applicable) to the listed Contact Person for the meeting. Comments relate to the May 28, 2025 meeting and will be considered by the Council.
Accommodations Available for Virtual Attendance
If you need special assistance to view the virtual meeting (for example, sign language interpretation), you should notify the Contact Person or use the Federal Relay at 1-800-877-8339 in advance of the May 28, 2025 meeting so reasonable accommodations can be provided.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-17438, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings in late September 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers applying for funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
Previous / Next Documents
Previous: 2025-05148, International Product Change-Priority Mail Express International, Priority Mail International & First-Class Package International Service Agreement
The Postal Service wants to add a new international shipping deal for Priority Mail Express International, Priority Mail International, and First-Class Package International Service. This change affects businesses and customers who send packages overseas, aiming to offer better pricing and service options. The request is now with the Postal Regulatory Commission, so keep an eye out for updates soon!
Next: 2025-05152, National Institute of General Medical Sciences; Notice of Meeting
The National Institute of General Medical Sciences is holding a virtual public meeting on May 22, 2025, to discuss research programs and review grant applications. This meeting affects researchers and organizations seeking funding, with some sessions open to everyone and others closed to protect privacy and trade secrets. If you want to join or send comments, act fast—deadlines for requests and input are just days before the meeting!